Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 6/20 | 0.50 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6150719 | 0.92 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL5973945 | 0.92 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL5974301 | 0.91 | KMT2A (0.53) | FURINF10KMT2AALDH1A1MAPT | |
| SCHEMBL5973917 | 0.90 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL6149232 | 0.90 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL5442050 | 0.90 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL8445590 | 0.90 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL8446705 | 0.90 | FURIN (0.56) | FURINF10KMT2APARP1PARP10 | |
| SCHEMBL27674139 | 0.85 | KMT2A (0.64) | KMT2APARP1PARP10ALDH1A1MAPT | |
| SCHEMBL5974764 | 0.84 | HDAC3 (0.54) | FURINF10KMT2APARP1PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004016258-A1 | THERAPEUTICAL USE OF GUANYLHYDRAZONES FOR TREATING DISEASES ASSOCIATED WITH DENDRITIC CELL MATURATION | MONDOBIOTECH LABORATORIES ANSTALT (CH) | 2004-02-26 | — | — | WO | claimed |
| US-20030203969-A1 | Pharmaceutically active aromatic guanylhydrazones | AXXIMA PHARMACEUTICALS AG (DE) | 2003-10-30 | — | — | US | claimed |
| WO-2003006426-A1 | AROMATIC GUANYLHYDRAZONES AS EFFECTIVE COMPOUNDS AGAINST NEURODISEASES | AXXIMA PHARMACEUTICALS AG (DE) | 2003-01-23 | — | — | WO | claimed |
| EP-1255541-A2 | PHARMACEUTICALLY ACTIVE AROMATIC GUANYLHYDRAZONES | Axxima Pharmaceuticals Aktiengesellschaft (DE) | 2002-11-13 | — | — | EP | claimed |
| WO-2002000613-A2 | INHIBITORS OF HEPATITIS B VIRUS INFECTION | AXXIMA PHARMACEUTICALS AG (DE) | 2002-01-03 | — | — | WO | claimed |
| WO-2001056553-A2 | PHARMACEUTICALLY ACTIVE AROMATIC GUANYLHYDRAZONES | AXXIMA PHARMACEUTICALS AG (DE) | 2001-08-09 | — | — | WO | claimed |
| EP-1255541-B1 | AROMATIC GUANYLHYDRAZONE FOR THE TREATMENT OF RESISTANT VIRAL INFECTIONS | BEVEC DORIAN (DE) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004016258-A1 | THERAPEUTICAL USE OF GUANYLHYDRAZONES FOR TREATING DISEASES ASSOCIATED WITH DENDRITIC CELL MATURATION | MONDOBIOTECH LABORATORIES ANSTALT (CH) | 2004-02-26 | — | — | WO | disclosed |
| EP-1389480-A1 | Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation | Mondobiotech Interferon SA (CH) | 2004-02-18 | — | — | EP | disclosed |
| US-20030203969-A1 | Pharmaceutically active aromatic guanylhydrazones | AXXIMA PHARMACEUTICALS AG (DE) | 2003-10-30 | — | — | US | disclosed |
| WO-2003006426-A1 | AROMATIC GUANYLHYDRAZONES AS EFFECTIVE COMPOUNDS AGAINST NEURODISEASES | AXXIMA PHARMACEUTICALS AG (DE) | 2003-01-23 | — | — | WO | disclosed |
| CN-1098070-C | Guanylhydrazones for treating inflammatory conditions | PICOWER INST MED RES (US) | 2003-01-08 | — | — | CN | disclosed |
| EP-1255541-A2 | PHARMACEUTICALLY ACTIVE AROMATIC GUANYLHYDRAZONES | Axxima Pharmaceuticals Aktiengesellschaft (DE) | 2002-11-13 | — | — | EP | disclosed |
| WO-2002000613-A2 | INHIBITORS OF HEPATITIS B VIRUS INFECTION | AXXIMA PHARMACEUTICALS AG (DE) | 2002-01-03 | — | — | WO | disclosed |
| WO-2001056553-A2 | PHARMACEUTICALLY ACTIVE AROMATIC GUANYLHYDRAZONES | AXXIMA PHARMACEUTICALS AG (DE) | 2001-08-09 | — | — | WO | disclosed |
| EP-0746312-A4 | GUANYLHYDRAZONES FOR TREATING INFLAMMATORY CONDITIONS | PICOWER INST MED RES (US) | 1999-05-26 | — | — | EP | disclosed |
| US-5849794-A | Guanylhydrazones and their use to treat inflammatory conditions | THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) | 1998-12-15 | — | — | US | disclosed |
| CN-1144480-A | Guanylhydrazones for treating inflammatory conditions | PICOWER INST MED RES (US) | 1997-03-05 | — | — | CN | disclosed |
| EP-0746312-A1 | GUANYLHYDRAZONES FOR TREATING INFLAMMATORY CONDITIONS | THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) | 1996-12-11 | — | — | EP | disclosed |
| WO-1995019767-A1 | GUANYLHYDRAZONES FOR TREATING INFLAMMATORY CONDITIONS | THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) | 1995-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203969-A1 | Pharmaceutically active aromatic guanylhydrazones | DHPS, GGPS1, GMPS | FURIN 2883/4885F10 3183/4885KMT2A 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.